USPTO serial 79203776
ILOPERA
Reviewed by CopyMark Law Group
Reg. 5415064Status 709
- Filing date
- Status date
- Registration date
- Mar 6, 2018
- Examiner
- MICKLEBURGH, LINDA BOHANNON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ILOPERA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
GEN ILAÇ VE SAGLIK ÜRÜNLERI SANAYI VE TICARET ANONIM SIRKETI
TR
Other trademarks owned by GEN ILAÇ VE SAGLIK ÜRÜNLERI SANAYI VE TICARET ANONIM SIRKETI
GEN ILAÇ VE SAGLIK ÜRÜNLERI SANAYI VE TICARET ANONIM SIRKETI
TR
Other trademarks owned by GEN ILAÇ VE SAGLIK ÜRÜNLERI SANAYI VE TICARET ANONIM SIRKETI
GEN ILAÇ VE SAGLIK ÜRÜNLERI SANAYI VE TICARET ANONIM SIRKETI
TR
Other trademarks owned by GEN ILAÇ VE SAGLIK ÜRÜNLERI SANAYI VE TICARET ANONIM SIRKETI
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, medical and veterinary preparations for improving exercise capacity and symptoms in NYHA III and IV patients with Primary (idiopathic and familial) pulmonary hypertension and with Pulmonary hypertension due to scleroderma without co-existing interstitial pulmonary and for treatment of patients with advanced Thromboangitis obliterans (Buerger's disease) with critical limb ischemia in whom revascularization is not indicated, treatment of patients with severe peripheral arterial occlusive disease (PAOD), particularly in cases who carry a risk of amputation or cannot undergo angioplasty, treatment of patients with Raynaud's phenomenon irresponsive to other treatments and causing severe restriction; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary medical use, food for babies; dietary supplements for humans and animals; medical plasters, and materials for medical dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GEN ILAÇ VE SAGLIK ÜRÜNLERI SANAYI VE TICARET ANONIM SIRKETI
- Other trademarks owned by GEN ILAÇ VE SAGLIK ÜRÜNLERI SANAYI VE TICARET ANONIM SIRKETI
- Other trademarks owned by GEN ILAÇ VE SAGLIK ÜRÜNLERI SANAYI VE TICARET ANONIM SIRKETI
- Other trademarks in Class 005
- Similar marks named ILOPERA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 22, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 18, 2025 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 19, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Sep 19, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| May 20, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 20, 2024 | C71T | CANCELLED SECTION 71 | — |
| Aug 31, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 12, 2018 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jun 12, 2018 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jun 6, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 6, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 15, 2018 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 19, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 15, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 29, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 29, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 29, 2017 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 15, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 30, 2017 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Oct 30, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 25, 2017 | ALIE | ASSIGNED TO LIE | — |
| Oct 13, 2017 | PAPER RECEIVED | — | |
| May 5, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 13, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 13, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 12, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 11, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 4, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 31, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 27, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 23, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |